Welters MJ - Search Results

1

M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.

Heusinkveld M, de Vos van Steenwijk PJ, Goedemans R, Ramwadhdoebe TH, Gorter A, Welters MJ, van Hall T, van der Burg SH. Heusinkveld M, et al. Among authors: welters mj. J Immunol. 2011 Aug 1;187(3):1157-65. doi: 10.4049/jimmunol.1100889. Epub 2011 Jun 27. J Immunol. 2011. PMID: 21709158

2

The status of HPV16-specific T-cell reactivity in health and disease as a guide to HPV vaccine development.

van der Burg SH, de Jong A, Welters MJ, Offringa R, Melief CJ. van der Burg SH, et al. Among authors: welters mj. Virus Res. 2002 Nov;89(2):275-84. doi: 10.1016/s0168-1702(02)00196-x. Virus Res. 2002. PMID: 12445667 Review.

3

Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.

Welters MJ, de Jong A, van den Eeden SJ, van der Hulst JM, Kwappenberg KM, Hassane S, Franken KL, Drijfhout JW, Fleuren GJ, Kenter G, Melief CJ, Offringa R, van der Burg SH. Welters MJ, et al. Cancer Res. 2003 Feb 1;63(3):636-41. Cancer Res. 2003. PMID: 12566307

4

Chemically synthesized protein as tumour-specific vaccine: immunogenicity and efficacy of synthetic HPV16 E7 in the TC-1 mouse tumour model.

Welters MJ, Filippov DV, van den Eeden SJ, Franken KL, Nouta J, Valentijn AR, van der Marel GA, Overkleeft HS, Lipford G, Offringa R, Melief CJ, van Boom JH, van der Burg SH, Drijfhout JW. Welters MJ, et al. Vaccine. 2004 Dec 2;23(3):305-11. doi: 10.1016/j.vaccine.2004.06.008. Vaccine. 2004. PMID: 15530672

5

Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease.

Welters MJ, van der Logt P, van den Eeden SJ, Kwappenberg KM, Drijfhout JW, Fleuren GJ, Kenter GG, Melief CJ, van der Burg SH, Offringa R. Welters MJ, et al. Int J Cancer. 2006 Feb 15;118(4):950-6. doi: 10.1002/ijc.21459. Int J Cancer. 2006. PMID: 16152582 Free article.

6

Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy.

van der Burg SH, Bijker MS, Welters MJ, Offringa R, Melief CJ. van der Burg SH, et al. Among authors: welters mj. Adv Drug Deliv Rev. 2006 Oct 1;58(8):916-30. doi: 10.1016/j.addr.2005.11.003. Epub 2006 Aug 12. Adv Drug Deliv Rev. 2006. PMID: 16979788 Review.

7

Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists.

Welters MJ, Bijker MS, van den Eeden SJ, Franken KL, Melief CJ, Offringa R, van der Burg SH. Welters MJ, et al. Vaccine. 2007 Feb 9;25(8):1379-89. doi: 10.1016/j.vaccine.2006.10.049. Epub 2006 Nov 7. Vaccine. 2007. PMID: 17123670

8

Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.

van der Burg SH, Piersma SJ, de Jong A, van der Hulst JM, Kwappenberg KM, van den Hende M, Welters MJ, Van Rood JJ, Fleuren GJ, Melief CJ, Kenter GG, Offringa R. van der Burg SH, et al. Among authors: welters mj. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12087-92. doi: 10.1073/pnas.0704672104. Epub 2007 Jul 5. Proc Natl Acad Sci U S A. 2007. PMID: 17615234 Free PMC article.

9

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.

Britten CM, Gouttefangeas C, Welters MJ, Pawelec G, Koch S, Ottensmeier C, Mander A, Walter S, Paschen A, Müller-Berghaus J, Haas I, Mackensen A, Køllgaard T, thor Straten P, Schmitt M, Giannopoulos K, Maier R, Veelken H, Bertinetti C, Konur A, Huber C, Stevanović S, Wölfel T, van der Burg SH. Britten CM, et al. Among authors: welters mj. Cancer Immunol Immunother. 2008 Mar;57(3):289-302. doi: 10.1007/s00262-007-0378-0. Epub 2007 Aug 25. Cancer Immunol Immunother. 2008. PMID: 17721783 Free PMC article.

10

Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.

Piersma SJ, Welters MJ, van der Hulst JM, Kloth JN, Kwappenberg KM, Trimbos BJ, Melief CJ, Hellebrekers BW, Fleuren GJ, Kenter GG, Offringa R, van der Burg SH. Piersma SJ, et al. Among authors: welters mj. Int J Cancer. 2008 Feb 1;122(3):486-94. doi: 10.1002/ijc.23162. Int J Cancer. 2008. PMID: 17955486 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page